MEDVi vs Willow: Which GLP-1 Provider Is Better?
A side-by-side comparison of MEDVi and Willow covering pricing, scores, medication types, insurance, and more to help you decide.
MEDVi
#9 of 31Compounded GLP-1 platform offering both oral and injectable options with flexible dosing and affordable pricing.
Visit MEDViWillow
#1 of 31Personalized GLP-1 weight loss with ongoing clinical support. The highest verified conversion rate among comprehensive care platforms.
Visit Willow| Feature | MEDVi | Willow |
|---|---|---|
| Our Score | 8.3/10 | 9.4/10 |
| Starting Price | $179/mo | $160/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | Users who want a low entry price with oral and injectable compounded options | Users who want a balance of quality care and reasonable pricing |
| Ranking | #9 | #1 |
Pros & Cons Compared
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Willow
Pros
- +Includes monthly provider check-ins and dose adjustments at no extra cost
- +Switch between brand-name and compounded mid-treatment without restarting
- +$160/mo all-in — no consultation fees, no shipping charges, no lab surcharges
- +90%+ patient retention rate after 3 months per their published outcomes data
Cons
- −Cash-pay only — no insurance billing, though they provide superbills for FSA/HSA
- −Founded in 2024 — less track record than Ro or Hims, though growth has been fast
Our Verdict
Willow edges out MEDVi with a score of 9.4/10 vs 8.3/10. If budget is your priority, Willow starts at $160/mo compared to MEDVi's $179/mo. Willow offers both brand-name and compounded medications, giving you more flexibility. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options. Choose Willow if you want: users who want a balance of quality care and reasonable pricing.